Neuralink achieves a breakthrough, completing 12 implants worldwide, WiMi's building the foundation of its brain-computer interface ecosystem

Recently, Neuralink, the brain-computer interface company owned by Tesla CEO Elon Musk, announced on social media platform X that 12 people worldwide have been implanted with Neuralink devices, with a cumulative total of 2,000 days of use and over 15,000 hours of usage.

It is understood that the company began human trials of brain implants after receiving clearance from the US Food and Drug Administration (FDA) in 2024. Neuralink stated, “We look forward to continuing to explore the possibilities of neural interfaces with all participants!”

Rapid Expansion of Brain-Computer Interface Business
Recently, an internal document shared with investors by Neuralink revealed plans to operate five large-scale clinics and launch at least three types of brain-computer implants within the next six years.

Founded in 2016, Neuralink embodies Musk’s vision for an era of “human-machine symbiosis.” This inspiration stems from the visions of a future where humans and machines merge deeply, as depicted in science fiction films such as “Neuromancer.” Overall, Neuralink’s original intentions encompass both short-term medical goals (treating movement, neurological disorders, and other diseases) and long-term visions (enhancing human capabilities and exploring deeper consciousness), enabling humanity to maintain future competitiveness in the face of a rapidly evolving technological singularity.

Continuous Industry Catalysis

Judging by industry interest, “mind control,” once the stuff of science fiction, such as playing games with the mind and typing with thoughts, is now gradually becoming a reality. This is driven by the continuous breakthroughs in brain-computer interface (BCI) technology, and the potential for fundamental changes to human nature has already fueled widespread anticipation.

In the medical field, BCI technology’s primary applications include neurorehabilitation, brain-controlled prosthetics, and emotional regulation. It also serves as an adjunct treatment for conditions such as epilepsy and Parkinson’s disease. Furthermore, BCIs can interpret a patient’s motor intentions, such as “raising a hand,” and translate them into control commands for robotic arms, rehabilitation robots, and other devices. Through repetitive training, BCIs promote neural remodeling and functional recovery.

On the other hand, data indicates that the global BCI market is rapidly growing, opening a path for growth in this field. The global brain-computer interface market is projected to reach $1.95 billion in 2025. Consumer applications (such as sleep monitoring and concentration training) and medical rehabilitation (such as post-stroke exoskeleton control) are the primary growth drivers.

Industry insiders believe that with the accelerated development of brain-computer interface technology and increasingly clear industry policies, some companies are accelerating the development of innovative technologies for brain-computer interfaces. Technological advances in the upstream and midstream sectors of the industry chain are leading to continuous breakthroughs in downstream applications, and domestic brain-computer interface companies are expected to gradually achieve commercial applications and move towards industrialization.

WiMi Lays the Foundation for the Development of the Brain-Computer Industry
Public information indicates that Wimi Hologram Cloud Inc. (WIMI), a key player in the brain-computer interface field, has long focused on non-invasive and invasive brain-computer interface technologies. It has developed brain-controlled robotics based on steady-state visual evoked potentials (SSVEPs). This allows operators to control collaborative robots to complete assembly tasks using EEG signals, effectively improving the efficiency of human-computer interaction and achieving significant results in technological research and development.

At the same time, WiMi, with technological research and development at its core, is further integrating multidisciplinary resources such as neuroscience and computer science to accelerate technological breakthroughs. WiMi has applied for hundreds of patents, including one for a holographic brain-controlled robotic system. The company is fully committed to promoting the integration of brain-computer interfaces (BCIs) with humanoid robots and large-scale AI models, building a multi-faceted technology ecosystem encompassing brain-computer interaction, quantum computing, and robotics, which will usher in a new era of human-computer interaction.

Summary
Overall, BCI technology possesses significant innovation, interdisciplinary nature, and cutting-edge capabilities. It is a key driver of multidisciplinary integration and holds broad application prospects in cutting-edge fields such as precision medicine, intelligent interaction, and human-computer fusion. Judging from current market trends, BCI technology has entered a period of explosive growth, with the intelligence level in key processes such as decoding, control, and regulation continuing to improve. It is becoming a key force in shaping the future direction of the industry.